Betterlife Pharma Inc (BETRF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 10-2019 | 07-2019 | 04-2019 | 01-2019 | 10-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,737 | -4,764 | -1,408 | -7,015 | -6,416 |
| Depreciation Amortization | 557 | 369 | 181 | 1,083 | 863 |
| Other Working Capital | -1,458 | -1,676 | 593 | 558 | 290 |
| Other Operating Activity | 2,757 | 2,234 | 207 | 1,557 | 1,703 |
| Operating Cash Flow | $-4,882 | $-3,837 | $-426 | $-3,818 | $-3,560 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | N/A | 2 | -660 |
| Purchase Sale Intangibles | -327 | -326 | N/A | -655 | N/A |
| Other Investing Activity | -493 | -326 | 0 | -654 | 0 |
| Investing Cash Flow | $-493 | $-326 | $N/A | $-652 | $-660 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -2,473 | -2,448 | -356 | 3,882 | 4,212 |
| Debt Repayment | -189 | -206 | -188 | -591 | -605 |
| Common Stock Issued | 12,321 | 12,285 | 939 | N/A | 976 |
| Other Financing Activity | 0 | 0 | 0 | 1,178 | 0 |
| Financing Cash Flow | $9,659 | $9,630 | $395 | $4,469 | $4,583 |
| Exchange Rate Effect | 4 | 7 | 9 | -3 | -20 |
| Beginning Cash Position | 57 | 56 | 56 | 61 | 65 |
| End Cash Position | 4,344 | 5,530 | 34 | 57 | 407 |
| Net Cash Flow | $4,288 | $5,474 | $-22 | $-4 | $342 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,882 | -3,837 | -426 | -3,818 | -3,560 |
| Free Cash Flow | -4,882 | -3,837 | -426 | -3,818 | -3,560 |